BIM

114.7

+0.7%↑

SRT3

228.7

-0.74%↓

ICAD

21.1

-1.49%↓

BIM

114.7

+0.7%↑

SRT3

228.7

-0.74%↓

ICAD

21.1

-1.49%↓

BIM

114.7

+0.7%↑

SRT3

228.7

-0.74%↓

ICAD

21.1

-1.49%↓

BIM

114.7

+0.7%↑

SRT3

228.7

-0.74%↓

ICAD

21.1

-1.49%↓

BIM

114.7

+0.7%↑

SRT3

228.7

-0.74%↓

ICAD

21.1

-1.49%↓

Search

Gerresheimer AG

Avatud

SektorTervishoid

54.4 1.59

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

52.35

Max

54.55

Põhinäitajad

By Trading Economics

Sissetulek

-56M

-17M

Müük

-49M

520M

P/E

Sektori keskmine

22.741

57.333

Aktsiakasum

0.46

Dividenditootlus

2.41

Kasumimarginaal

-3.363

Töötajad

13,632

EBITDA

-33M

84M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+83.02% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

2.41%

2.63%

Järgmine tulemuste avaldamine

10. juuli 2025

Turustatistika

By TradingEconomics

Turukapital

-40M

1.8B

Eelmine avamishind

52.81

Eelmine sulgemishind

54.4

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

Gerresheimer AG Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

4. apr 2025, 10:15 UTC

Suurimad hinnamuutused turgudel
Omandamised, ülevõtmised, äriostud

Gerresheimer Shares Fall After Report That KKR Exited Consortium Seeking Bid

4. apr 2025, 09:39 UTC

Omandamised, ülevõtmised, äriostud

KKR Drops Out of Consortium Attempting Gerresheimer Takeover, Bloomberg Says, Citing Sources

13. mai 2024, 11:16 UTC

Peamised uudised

German Companies Bet on AI But Payoff Could Be Years Away -- Talking Markets

Võrdlus sarnastega

Hinnamuutus

Gerresheimer AG Prognoos

Hinnasiht

By TipRanks

83.02% tõus

12 kuu keskmine prognoos

Keskmine 98.1 EUR  83.02%

Kõrge 122.5 EUR

Madal 84.5 EUR

Põhineb 12 Wall Streeti analüütiku instrumendi Gerresheimer AG 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

12 ratings

11

Osta

1

Hoia

0

Müü

Tehniline skoor

By Trading Central

53.05 / 53.85Toetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Strong Bearish Evidence

Pikk perspektiiv

Neutral Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Gerresheimer AG

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.